Horizon Therapeutics (HZNP) rose 1.1%, at least partly amid some speculation about a potential settlement with the Federal Trade Commission
https://seekingalpha.com/news/4004914-horizon-therapeutics-gains-amid-speculation-on-potential-ftc-settlement-on-amgen
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.